These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6459100)

  • 1. Antibiotic concentrations in blood and tissue. Intraoperative ischemia as a model for the determination of tissue concentrations using mezlocillin and oxacillin as examples.
    Adam D; Wilhelm K; Chyský V
    Arzneimittelforschung; 1981; 31(11):1972-6. PubMed ID: 6459100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Penetration of mezlocillin and oxacillin into the glandular and adipose tissue of the breast after simultaneous intravenous infusion. A pharmacokinetic study].
    Bordt J; Holzgreve W; Wagner H; Adam D
    Geburtshilfe Frauenheilkd; 1983 Jan; 43(1):18-9. PubMed ID: 6219911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mezlocillin concentrations in human bone tissue].
    Vent J
    Arzneimittelforschung; 1979; 29(12a):1969-71. PubMed ID: 543904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of hydroxyapatite for determination of antibiotic concentrations in bone].
    Wittmann DH; Berghoff D; Reynders-Frederix V; Schassan HH
    Arzneimittelforschung; 1983; 33(3):423-6. PubMed ID: 6307318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience with the combination mezlocillin/oxacillin in severe bacterial infections in a children's surgical ward (author's transl)].
    Kurz R
    Arzneimittelforschung; 1979; 29(12a):2014-7. PubMed ID: 543915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies with a mezlocillin-oxacillin combination in a children's intensive care ward].
    Schöch G
    Arzneimittelforschung; 1979; 29(12a):2017-20. PubMed ID: 543916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic studies on broad spectrum antibiotic combinations of penicillin and oxacillin in normal volunteers (author's transl)].
    Adam D; Bauer W; Seitz B; Voigt I
    Arzneimittelforschung; 1979; 29(11):1769-804. PubMed ID: 543889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid penetration of mezlocillin.
    Modai J; Pierre J; Bergogne-Berezin E; Avril MF
    Arzneimittelforschung; 1979; 29(12a):1967-9. PubMed ID: 543903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between the pharmacokinetic properties of mezlocillin when given intravenously as a bolus injection or as an infusion.
    Ohlsson H; Bergan T
    Arzneimittelforschung; 1979; 29(12a):1958-9. PubMed ID: 543900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic studies on the penetration of azlocillin and mezlocillin into bone and tissue fluid (author's transl)].
    Wittmann DH; Schassan HH; Seidel H
    Arzneimittelforschung; 1981; 31(7):1157-62. PubMed ID: 6456009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of childhood meningitis with mezlocillin.
    Llorens-Terol J; Lobato A; Adam D
    Arzneimittelforschung; 1979; 29(12a):2001-2. PubMed ID: 543912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy with an antibiotic combination mezlocillin/oxacillin and clinical experience/Second communication: Children (author's transl)].
    Chyský V; Hullmann R
    Arzneimittelforschung; 1979; 29(12a):2028-31. PubMed ID: 543917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of a multicentric clinical study of mezlocillin in Japan (author's transl)].
    Fujii R
    Arzneimittelforschung; 1979; 29(12a):2005-8. PubMed ID: 396930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Degradation of Azlocillin and Mezlocillin / I. Behaviour in biological material and buffer (author's transl)].
    Gundert-Remy U; Weber E
    Arzneimittelforschung; 1981; 31(12):2041-4. PubMed ID: 6460506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic studies with a combination of mezlocillin-oxacillin].
    Adam D; Bauer W
    Arzneimittelforschung; 1979; 29(12a):1971-6. PubMed ID: 543905
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience with mezlocillin in infections of mouth and jaw (author's transl)].
    Shimizu M; Amagasa M; Ohnishi M; Yuki K; Sato T; Yoshida H; Do K; Ueno M
    Arzneimittelforschung; 1979; 29(12a):1987-9. PubMed ID: 543908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local tolerance of i.m. mezlocillin injection.
    Belli L; Gandolfo S; Varela M; Gennaro EA
    Arzneimittelforschung; 1979; 29(12a):1985-7. PubMed ID: 543907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].
    Verbist L; Tjandramaga TB; Verbesselt R; de Schepper PJ
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):347-52. PubMed ID: 6460974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed combination mezlocillin/oxacillin injected intramuscularly. Comparative study of local tolerability compared with ampicillin and determination of effectiveness and tolerability in the treatment of surgical and urinary tract infections.
    Belli L; Freylejer A; Ginesín LM; Ríos JF; Gandolfo S
    Arzneimittelforschung; 1980; 30(10):1804-7. PubMed ID: 6449205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative diffusion of fusidic acid, oxacillin, and pristinamycin in dermal interstitial fluid after repeated oral administration].
    Vaillant L; Le Guellec C; Jehl F; Barruet R; Sorensen H; Roiron R; Autret-Leca E; Lorette G
    Ann Dermatol Venereol; 2000 Jan; 127(1):33-9. PubMed ID: 10717560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.